Market Analysis & Commercial Strategy
Case Details
Start Day: 18/07/2024
Clients: Molecular Diagnostics Company
Tags: Rapid Molecular Testing, Pcrun Platform, Point Of Care Testing, China Ivd Market, Infectious Disease Diagnostics, Molecular Diagnostics China, Regulatory Strategy China, Clinical Adoption China, Healthcare Innovation China, Diagnostic Market Entry, Competitor Benchmarking Diagnostics, Point Of Care Pcr, Chinese Healthcare System
Project Duration: 10 Months
Let’s Work Together for Development
Call us directly, submit a sample or email us!
The Story
Our client aims to introduce its rapid PCRun diagnostic platform for leptospirosis detection into the Chinese in vitro diagnostics (IVD) market, targeting faster, more accurate point-of-care solutions.
A global diagnostics company aims to introduce its rapid PCRun diagnostic test for leptospirosis into the competitive and regulated Chinese in vitro diagnostics (IVD) market.
What Did Octavus Do
Successful entry into China’s IVD market could transform leptospirosis diagnosis by reducing time to treatment, improving patient outcomes, and capturing value in a large, underserved segment despite strong incumbent competition and regulatory hurdles.
Data Analysis Chart
The Results
Octavus proposed these solutions based on the research conducted for Client.
